Patents by Inventor Michael J. McPherson

Michael J. McPherson has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • GLUCOCORTICOID RECEPTOR AGONIST AND IMMUNOCONJUGATES THEREOF
    Publication number: 20220354959
    Abstract: Provided herein are glucocorticoid receptor agonist immunoconjugates, glucocorticoid receptor agonists, and methods of using the same, e.g., to treat autoimmune or inflammatory diseases.
    Type: Application
    Filed: May 12, 2021
    Publication date: November 10, 2022
    Applicant: AbbVie Inc.
    Inventors: Michael J. McPherson, Adrian D. Hobson, Martin E. Hayes, Christopher C. Marvin, Diana Schmidt, Wendy Waegell, Christian Goess, Jason Z. Oh, Axel Hernandez, Jr., John T. Randolph
  • ANTI-CD40 ANTIBODY DRUG CONJUGATES
    Publication number: 20220265842
    Abstract: Provided herein are anti-CD40 antibody drug conjugates comprising a radical of Formula (I), wherein R1, R2, and R3 are as defined herein. Further provided are anti-CD40 antibody drug conjugates of Formula (II), wherein Z, R, AA1, AA2, AA3, m, p, q, n, w, R1, R2, and R3 are as defined herein. Further provided are pharmaceutical compositions and kits thereof, and methods of using same.
    Type: Application
    Filed: November 29, 2018
    Publication date: August 25, 2022
    Applicant: AbbVie Inc.
    Inventors: Adrian D. Hobson, Jason Z. Oh, Michael J. McPherson, Wendy Waegell, Shaughn H. Bryant, Axel Hernandez, Jr., Claire L. Ihle, Christopher C. Marvin, Olivia A. Perng, Ling C. Santora, Lu Wang, Lu Wang
  • GLUCOCORTICOID RECEPTOR AGONIST AND IMMUNOCONJUGATES THEREOF
    Publication number: 20210015938
    Abstract: Provided herein are glucocorticoid receptor agonist immunoconjugates, glucocorticoid receptor agonists, and methods of using the same.
    Type: Application
    Filed: July 31, 2020
    Publication date: January 21, 2021
    Applicant: AbbVie Inc.
    Inventors: Adrian D. Hobson, Michael J. McPherson, Wendy Waegell, Christian Goess, Axel Hernandez, Jr., Lu Wang, Lu Wang, Christopher C. Marvin, Ling C. Santora
  • GLUCOCORTICOID RECEPTOR AGONIST AND IMMUNOCONJUGATES THEREOF
    Publication number: 20200338208
    Abstract: Provided herein are glucocorticoid receptor agonist immunoconjugates, glucocorticoid receptor agonists, and methods of using the same, e.g., to treat autoimmune or inflammatory diseases.
    Type: Application
    Filed: April 16, 2020
    Publication date: October 29, 2020
    Applicant: AbbVie Inc.
    Inventors: Michael J. McPherson, Adrian D. Hobson, Martin E. Hayes, Christopher C. Marvin, Diana Schmidt, Wendy Waegell, Christian Goess, Jason Z. Oh, Axel Hernandez, JR., John T. Randolph
  • Glucocorticoid receptor agonist and immunoconjugates thereof
    Patent number: 10668167
    Abstract: Provided herein are glucocorticoid receptor agonist immunoconjugates, glucocorticoid receptor agonists, and methods of using the same, e.g., to treat autoimmune or inflammatory diseases.
    Type: Grant
    Filed: May 10, 2019
    Date of Patent: June 2, 2020
    Assignee: AbbVie Inc.
    Inventors: Michael J. McPherson, Adrian D. Hobson, Martin E. Hayes, Christopher C. Marvin, Diana Schmidt, Wendy Waegell, Christian Goess, Jason Z. Oh, Axel Hernandez, Jr., John T. Randolph
  • GLUCOCORTICOID RECEPTOR AGONIST AND IMMUNOCONJUGATES THEREOF
    Publication number: 20190262465
    Abstract: Provided herein are glucocorticoid receptor agonist immunoconjugates, glucocorticoid receptor agonists, and methods of using the same, e.g., to treat autoimmune or inflammatory diseases.
    Type: Application
    Filed: May 10, 2019
    Publication date: August 29, 2019
    Applicant: AbbVie Inc.
    Inventors: Michael J. MCPHERSON, Adrian D. HOBSON, Martin E. HAYES, Christopher C. MARVIN, Diana SCHMIDT, Wendy WAEGELL, Christian GOESS, Jason Z. OH, Axel HERNANDEZ, Jr., John T. RANDOLPH
  • GLUCOCORTICOID RECEPTOR AGONIST AND IMMUNOCONJUGATES THEREOF
    Publication number: 20180126000
    Abstract: Provided herein are glucocorticoid receptor agonist immunoconjugates, glucocorticoid receptor agonists, and methods of using the same, e.g., to treat autoimmune or inflammatory diseases.
    Type: Application
    Filed: June 1, 2017
    Publication date: May 10, 2018
    Applicant: AbbVie Inc.
    Inventors: Michael J. MCPHERSON, Adrian D. HOBSON, Martin E. HAYES, Christopher C. MARVIN, Diana SCHMIDT, Wendy WAEGELL, Christian GOESS, Jason Z. OH, Axel HERNANDEZ, JR., John T. RANDOLPH
  • DUAL VARIABLE DOMAIN IMMUNOGLOBULINS AND USES THEREOF
    Publication number: 20150232550
    Abstract: Engineered multivalent and multispecific binding proteins, methods of making, and their uses in the prevention, diagnosis, and/or treatment of disease are provided.
    Type: Application
    Filed: April 17, 2015
    Publication date: August 20, 2015
    Inventors: Tariq Ghayur, Jochen G. Salfeld, Michael J. McPherson
  • Dual variable domain immunoglobulins and uses thereof
    Patent number: 9046513
    Abstract: Engineered multivalent and multispecific binding proteins, methods of making, and their uses in the prevention, diagnosis, and/or treatment of disease are provided.
    Type: Grant
    Filed: August 25, 2011
    Date of Patent: June 2, 2015
    Assignee: AbbVie Inc.
    Inventors: Tariq Ghayur, Jochen G. Salfeld, Michael J. McPherson
  • DUAL VARIABLE DOMAIN IMMUNOGLOBULINS AND USES THEREOF
    Publication number: 20140308286
    Abstract: The present invention relates to engineered multivalent and multispecific binding proteins, methods of making, and specifically to their uses in the prevention, diagnosis, and/or treatment of disease.
    Type: Application
    Filed: March 19, 2014
    Publication date: October 16, 2014
    Applicant: AbbVie Inc.
    Inventors: Tariq Ghayur, Jochen G. Salfeld, Michael J. McPherson, Maria C. Harris, Junjian Liu, Peter C. Isakson, Jijie Gu
  • Dual variable domain immunoglobulins and uses thereof
    Patent number: 8722855
    Abstract: The present invention relates to engineered multivalent and multispecific binding proteins, methods of making, and specifically to their uses in the prevention, diagnosis, and/or treatment of disease.
    Type: Grant
    Filed: October 28, 2010
    Date of Patent: May 13, 2014
    Assignee: AbbVie Inc.
    Inventors: Tariq Ghayur, Jochen G. Salfeld, Michael J. McPherson, Maria C. Harris, Junjian Liu, Peter C. Isakson, Jijie Gu
  • DUAL VARIABLE DOMAIN IMMUNOGLOBULINS AND USES THEREOF
    Publication number: 20120087858
    Abstract: Engineered multivalent and multispecific binding proteins, methods of making, and their uses in the prevention, diagnosis, and/or treatment of disease are provided.
    Type: Application
    Filed: August 25, 2011
    Publication date: April 12, 2012
    Inventors: Tariq Ghayur, Jochen G. Salfeid, Michael J. McPherson
  • DUAL VARIABLE DOMAIN IMMUNOGLOBULINS AND USES THEREOF
    Publication number: 20110212094
    Abstract: The present invention relates to engineered multivalent and multispecific binding proteins, methods of making, and specifically to their uses in the prevention, diagnosis, and/or treatment of disease.
    Type: Application
    Filed: October 28, 2010
    Publication date: September 1, 2011
    Applicant: ABBOTT LABORATORIES
    Inventors: Tariq Ghayur, Jochen G. Salfeld, Michael J. McPherson, Maria C. Harris, Junjian Liu, Peter C. Isakson, Jijie Gu
  • Plant parasitic nematode control
    Patent number: 5589622
    Abstract: A method of controlling nematodes, the method includes the steps of identification of a gene induced within a successfully infected plant by nematode infection of said plant and modifying the gene to confer nematode resistance to the plant.
    Type: Grant
    Filed: December 13, 1994
    Date of Patent: December 31, 1996
    Assignee: Advanced Technologies (Cambridge) Ltd.
    Inventors: Sarah J. Gurr, Michael J. McPherson, Howard J. Atkinson, Dianna J. Bowles